3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
6
Gynecologic
5
Thoracic
2
Other solid neoplasm
2
Sarcoma
1
Conditions
Sarcoma
2
Rhabdomyosarcoma
2
Ovarian Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Wilms Tumor
1
Stomach Neoplasms
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Brain Neoplasms
1
Adrenocortical Carcinoma
1
Adenocarcinoma
1
Interventions
Cisplatin
5
Carboplatin
5
Cyclophosphamide
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
pembrolizumab
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Irinotecan
3
Gemcitabine
3
Fluorouracil
3
Docetaxel
3
Capecitabine
3
tislelizumab
2
fludarabine
2
Specimen Handling
2
Riluzole
2
Quality of Life
2
Psychiatric Rehabilitation
2
Oncolytic Virotherapy
2
Observation
2
Fluorodeoxyglucose F18
2
Fluorescein
2
Floxuridine
2
Filgrastim
2
Drug Therapy
2
Cetuximab
2
umbralisib
1
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Cytoreduction Surgical Procedures
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled